The study of the non-viral gene delivery process at the molecular level, e.g. during the transfection of mammalian cells, is currently limited by difficulties to specifically detect the transfected plasmid DNA within the cells. Herein we describe the in vivo production of 5-bromodeoxyuridine-(5-BrdU) labelled plasmid DNA by a thymine-requiring Escherichia coli strain leading to 92 ± 15 % BrdU incorporation while minimizing plasmid structure alteration.
The majority of these studies used intercalating or fluorescent dyes for labelling the pDNA preliminary to transfection [1, 2] . It has been recognized, however, that such labels will inevitably modify the polarity of the plasmid and thus potentially alter its intracellular trafficking as has, e.g., been shown for the Hoechst 33258 dye [3] .
The thymidine analogue 5-bromodeoxyuridine (BrdU) can specifically replace the thymidine residue in DNA molecules [4] . An immunoenzymatic detection procedure, based on the use of F o r P e e r R e v i e w 4 a monoclonal antibody specific for 5-bromodeoxyuridine (BrdU), has been described for BrdU-labelled DNA in DNA-DNA and DNA-RNA hybridization assays involving BrdUlabelled probes [5, 6] . BrdU labelling of genomic DNA has also been used as a tool for assessing metabolic activity in mammalian cells and tissues via DNA synthesis [7] under conditions where low amounts of the label are integrated into the genomic DNA. The in vivo incorporation of BrdU into plasmid DNA by E. coli was first proposed by Kitazawa [8] leading to a substitution of approximately 80 % of T by BrdU. According to the authors, the labelled plasmid could later be used as probe for hybridization after restriction endonuclease digestion.
El Ouahabi and colleagues labelled small amounts of plasmid DNA using a modified nicktranslation protocol and demonstrated that BrdU-labelling can be a useful tool to visualize exogenous DNA after transfection [9] .
Herein we describe an improved method for the in vivo production of BrdU-labelled plasmid DNA in a thymidine-requiring Escherichia coli strain, leading to 92 ± 15 % BrdU incorporation. Labelled plasmid DNA was produced at the milligram scale using a two-stage growth/production process. The possible relevance of this system for investigating intracellular events during gene delivery is demonstrated by visualising BrdU-labelled pDNA within the cytoplasm of Chinese Hamster Ovary (CHO) cells after electroporation and polyfection using polyethyleneimine (PEI) as transfection agent. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 plasmid DNA were diluted to 300 µL in 150 mM NaCl and vortexed. Then, 9.9 µL of PEI solution (10 µM) was added to the pDNA-NaCl solution, which was the vortexed and incubated for 10 min at room temperature for complex formation. Thereafter, the PEI/DNA complexes were added to the cells (time 0) and the plates were briefly centrifuged (200 g, 5 min, 4 °C). The cells were incubated at 37 °C and 5 % CO 2 for 4 hours, at which time the medium was replaced with 2 mL of RPMI-10 % FCS. Incubation was continued until the indicated time. Note: cells that were evaluated at time points shorter than 4 hours did not receive a medium replacement after transfection.
Materials and Methods

Materials
For electroporation, the cells were suspended in cold RPMI 1640 without FCS at a density of 2 x 10 7 cells mL -1 . A volume of 0.25 mL was transferred to a sterile electroporation cuvette (Thermo Electro Corporation, 50 x 4 mm) and 20 µg plasmid DNA in 250 µL RPMI 1640 was added to the cells. After 10 min incubation at room temperature, the aliquot was electroporated using a Bio-Rad Gene Pulser-Transfection Apparatus at 500 µF and 300 V. After receiving the electric pulse, the cells were incubated in the cuvette for 10 min at 37 °C before Afterward, the blot was scanned and signal intensities analyzed using the integrated density function in ImageJ [12] . For detection of the BrdU-pDNA in the polyplex, the PEI/DNA complex was treated as described above for the naked pDNA and volumes corresponding to 15 to 450 ng pDNA were blotted on the membrane. Further treatment was as described above.
Polyplexes were in addition subjected to an 'acidic' denaturation protocol, in analogy to the one described below for intracellular DNA. For this polyplexes were incubated (after fixation in 4 % p-formaldehyde or not) for 30 min at room temperature in 0.5 % Triton X100 / 2 M HCl. The acid was neutralised by sufficient amounts of 1 M Tris HCl and the subsequent treatment was as described above.
In order to quantitate BrdU incorporated in the pDNA, the dot blot was calibrated as follows.
Firstly a PCR product with 100 % substitution of T by BrdU was prepared as described below.
In addition, the corresponding unlabelled PCR product was prepared using the GFP cDNA as The PCR products were purified using a commercial purification kit ("wizard plus SV mini columns" kit; Promega) according to the manufacturer's instructions. All PCR products were 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 peer-00508907, version 1 -7 Aug 2010 Escherichia coli chi-1776 strain was to be used. Since this strain is described to preferentially grow at 30 °C [14] , preliminary experiments were performed to compare the growth of this microorganism at 30 and 37 °C. In our hands, decreasing the culture temperature did not improve, but rather reduced the growth rate (data not shown). Thus, we opted for performing further experiments at 37 °C.
The in vivo labelling of plasmid DNA (pDNA) with the thymidine analogue BrdU has been, to our knowledge, described only once in the literature [8] . In that case, the authors used large amount of the thymidine analogue BrdU (500 mg/L culture medium) corresponding to 8-to 60-fold higher quantity than used by other groups for genomic labelling [e.g. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 peer-00508907, version 1 -7 Aug 2010 F o r P e e r R e v i e w 11 the published data [8] may be due to the use of different strains of bacterial, as the bacterial strain used was unfortunately not specified in the previous publication. On the other hand, our results are in agreement with the data published by Hackett and Hanawalt [16] , which described a marked preference of a thymidine requiring bacteria strain for thymidine over BrdU.
Based on the facts that low amounts of BrdU were not toxic to the bacteria and that limited growth in the presence of BrdU was apparently possible, the following two-stage protocol was derived for in vivo labelling of pDNA with BrdU. The bacteria were first grown in the standard thymidine-containing medium until the mid-exponential phase was reached ('growth phase'). At this point (OD 600 ≈ 1.3), the bacteria were recovered and resuspended at OD 600 = 0.3 in the BrdU medium ('labelling phase') where they were again allowed to grow overnight.
Compared to direct cultivation in BrdU medium, this new protocol led to bacteria concentrations at the end of the culture (OD 600 = 2.40), which were similar to cell densities obtained in case of cultivations in the standard thymidine-containing medium. The two-stage process was scaled up to 100 mL and allowed the preparation of up to 10 µg of BrdU-pDNA per mL of bacterial culture at high purity (OD 260/280 ratio: 1.98). Average yields for the BrdU-labelled pDNA were thus approximately 70 % of those obtained for unlabelled pDNA prepared by the standard procedure. Finally, we confirmed by analysis on agarose gel that the incorporation of BrdU into the pDNA did not influence the content of the supercoiled topoisomer in the plasmid preparation or the restriction pattern (data not shown).
Quantitation of the BrdU-labelling index by dot-blot.
For assessment of the BrdU-labelling index of the prepared pDNA, a dot-blotting technique was adapted that had previously been described as accurate and efficient for proliferation DNA quantitation in animal tissues [11] . In particular, we amplified the GFP cDNA by PCR in the presence of BrdUTP instead of dTTP. This experimental set up assured 100 % substitution of T by BrdU in the PCR product. In addition, standard PCR products and plasmids were On the basis of these results, 0 to 454 ng of pDNA isolated from bacteria grown on BrdU medium were dot-blotted in duplicate to quantitate the substitution of T by BrdU and to calculate the BrdU-labelling index. For this purpose, the quantity of applied DNA was converted into thymidine units and the amount of BrdU-units was determined by dot-blotting and subsequent densitometric analysis. According to these measurements, the labelling protocol described in this work achieves a BrdU-labelling index of 92 ± 15 %.
Subsequently, quantitation of BrdU-pDNA compacted in polyelectrolyte complexes with the polycation PEI was attempted via the dot-blot method. However, in this case no signal was obtained. This was not due to failure of the PEI/DNA-complex to bind to the membrane, since in cases where Rhodamine-labelled PEI was used to complex the DNA, the polymer could be shown to bind quantitatively to the membrane and to stay there throughout the required manipulations. However, as Ueda et al. showed, the anti-BrdU antibody preferentially binds to single-stranded DNA and denaturation is therefore essential for the dot-blotting method [11] .
In the protocol suggested by this author and used by us, denaturation is achieved by strongly [17, 18] , we first verified that the pH during the denaturation step was in the required pH range, which was the case. Our inability to detect pDNA could thus only have been due to a complete loss of the DNA, e.g. during the washing steps, which is difficult to imagine even though at pH 12 PEI will be mostly neutralised, i.e. less able to compact the DNA, orquite the contrary -due to the fact that in spite of its likely denaturation, the pDNA strands remain so tightly compacted in the polyplex that they are in fact inaccessible to the antibody similar to the situation in double stranded DNA. In case of PEI-DNA polyplexes containing native DNA it has, e.g. been shown that compaction can be tight enough to prevent the insertion of intercalating dyes such as ethidium bromide. Thus, in order to exclude that our failure to detect the pDNA was due to the unsuitability of the alkaline denaturation step, we combined the dot blot assay with an acidic denaturation step similar to the one used below for the intracellular detection of BrdU-labelled pDNA, but were again unable to detect our pDNA within the polyplexes.
Intracellular detection of BrdU-labelled plasmid DNA in the cytosol of mammalian cells
In order to investigate the potential of the BrdU-labelling method for localising the DNA in- enter the nucleus, it is in view of the generally low efficiency of non-viral transfection methods more likely that the concentration of labelled pDNA inside the nucleus was simply below the detection limit of our method. It is also possible that the pDNA in the nuclei becomes masked to the antibody, e.g. due to an interaction with chromatin or some components of the transcription machinery. Incidentally, the one other work published on using BrdU-labelled plasmid DNA also failed to detect the pDNA inside the nucleus [9] . In order to gain additional information on the cellular localisation of the BrdU-pDNA, we re-analysed the slides with a laser confocal microscope (LSM). The LSM-analysis confirmed the exclusive cytoplasmic localisation of the plasmid, Figure 3 , panel A.
The indirect proof of entry into the nucleus via the expression of the reporter gene was also not possible in case of the BrdU-labelled plasmid, since expression was not observed in these cases. However, when the unlabelled plasmid was used under otherwise similar transfection conditions, expression of the reporter gene (GFP) was seen as early as two hours post electro- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 peer-00508907, version 1 -7 Aug 2010 
Conclusions
Exhaustive labelling of in vivo synthesized pDNA with the thymidine analogue 5-bromodeoxyuridine-(5-BrdU) is possible using the two-stage protocol outlined in this contribution. The procedure leads to high T-substitution and has minimal influence on the structure and the restriction map of the plasmid product. Purification procedures are the same as those for non-labelled pDNA. The method contains no step that would prevent scale up to the bioreactor scale and hence constitutes a cheap and easy way of producing large quantities of labelled pDNA. This is a considerable improvement, e.g., in comparison to the nick-translation method proposed by El Ouahabi et al. [9] for the same purpose.
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Composition of the growth medium
